2 Phase 3 results coming in first half 2017. 5 to 10 bagger if successful. If only the smaller indication trial is successful should still get a double or triple due to the market cap being so low. Good luck
(1)
(0)
COSCIENS Biopharma Inc (CSCI) Stock Research Links